Organ Modelling | Whitepapers & Reports
Validating Cellesce’s Bioreactor Technology for the Expansion of Patient-derived Breast Cancer Organoids
Cellesce develops bioprocessing systems for the expansion of organoids in significant volumes in a way that minimises handling time and maximises reproducibility, with the long term goal of positioning organoid technology as a cost effective model for early-stage drug discovery.
Related Resources
